These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow. Beanlands R; Muzik O; Nguyen N; Petry N; Schwaiger M J Am Coll Cardiol; 1992 Sep; 20(3):712-9. PubMed ID: 1512353 [TBL] [Abstract][Full Text] [Related]
23. Kinetics of technetium-99m-Sestamibi and thallium-201 in a transient ischemic myocardium animal model: insight into the 'redistribution' phenomenon. Mousa SA; Cooney JM; Stevens S Cardiology; 1992; 81(2-3):157-63. PubMed ID: 1286474 [TBL] [Abstract][Full Text] [Related]
24. Extraction and retention of technetium-99m Q12, technetium-99m sestamibi, and thallium-201 in isolated rat heart during coronary acidemia. McGoron AJ; Gerson MC; Biniakiewicz DS; Roszell NJ; Washburn LC; Millard RW Eur J Nucl Med; 1997 Dec; 24(12):1479-86. PubMed ID: 9391182 [TBL] [Abstract][Full Text] [Related]
25. The effect of flow on technetium-99m-teboroxime (SQ30217) and thallium-201 extraction and retention in rabbit heart. Marshall RC; Leidholdt EM; Zhang DY; Barnett CA J Nucl Med; 1991 Oct; 32(10):1979-88. PubMed ID: 1919742 [TBL] [Abstract][Full Text] [Related]
27. Myocardial technetium-99m-teboroxime activity in acute coronary artery occlusion and reperfusion: relation to myocardial blood flow and viability. Abraham SA; Mirecki FN; Levine D; Nunn AD; Strauss HW; Gewirtz H J Nucl Med; 1995 Jun; 36(6):1062-8. PubMed ID: 7769429 [TBL] [Abstract][Full Text] [Related]
28. Comparison of technetium-99m sestamibi and thallium-201 retention characteristics in canine myocardium. Melon PG; Beanlands RS; DeGrado TR; Nguyen N; Petry NA; Schwaiger M J Am Coll Cardiol; 1992 Nov; 20(5):1277-83. PubMed ID: 1401632 [TBL] [Abstract][Full Text] [Related]
29. Myocardial accumulation and clearance of technetium 99m teboroxime at 100%, 75%, 50% and zero coronary blood flow in dogs. Pieri P; Yasuda T; Fischman AJ; Ahmad M; Moore R; Yaoita H; Strauss HW Eur J Nucl Med; 1991; 18(9):725-31. PubMed ID: 1936048 [TBL] [Abstract][Full Text] [Related]
30. Tomographic myocardial perfusion imaging with technetium-99m-teboroxime at rest and after dipyridamole. Li QS; Solot G; Frank TL; Wagner HN; Becker LC J Nucl Med; 1991 Oct; 32(10):1968-76. PubMed ID: 1919740 [TBL] [Abstract][Full Text] [Related]
31. Uptake kinetics of technetium-99m-methoxyisobutylisonitrile and thallium-201 in adult rat heart endothelial and fibroblast-like cells in comparison to myocytes. Caldwell JH; Mertens H; Linssen MC; van der Vusse GJ; Buell U; Kammermeier H J Nucl Med; 1992 Jan; 33(1):102-7. PubMed ID: 1530964 [TBL] [Abstract][Full Text] [Related]
32. [Detection of myocardial ischemia by 99mTc-Teboroxime myocardial SPECT: a comparison with 201Tl myocardial SPECT]. Miyakawa T; Nakai K; Moriai N; Kamata J; Adachi T; Chiba M; Ogiu N; Kasazuki T; Kato K; Takahashi T Kaku Igaku; 1993 Jun; 30(6):669-74. PubMed ID: 8345697 [TBL] [Abstract][Full Text] [Related]
33. Detection sensitivity of coronary artery stenosis by 99mTc-sestamibi and 201T1 in canine models of partial and subcritical stenosis. Mousa SA; Cooney JM Cardiology; 1991; 79(2):135-45. PubMed ID: 1834334 [TBL] [Abstract][Full Text] [Related]
34. [Characteristics of the myocardial SPECT images of 99mTc-MIBI and 99mTc-teboroxime]. Kuji I; Nakajima K; Taki J; Taniguchi M; Bunko H; Tonami N; Hisada K Kaku Igaku; 1992 Feb; 29(2):183-91. PubMed ID: 1532995 [TBL] [Abstract][Full Text] [Related]
35. First-pass radionuclide angiographic studies of left ventricular function with technetium-99m-teboroxime, technetium-99m-sestamibi and technetium-99m-DTPA. Williams KA; Taillon LA; Draho JM; Foisy MF J Nucl Med; 1993 Mar; 34(3):394-9. PubMed ID: 8382741 [TBL] [Abstract][Full Text] [Related]
36. Comparison between technetium-99m-teboroxime and thallium-201 dipyridamole planar myocardial perfusion imaging in detection of coronary artery disease. Labonté C; Taillefer R; Lambert R; Basile F; TonThat T; Jarry M; Léveillé J Am J Cardiol; 1992 Jan; 69(1):90-6. PubMed ID: 1729873 [TBL] [Abstract][Full Text] [Related]
37. New agents labelled with technetium 99m for myocardial perfusion imaging. Taillefer R Can Assoc Radiol J; 1992 Aug; 43(4):258-66. PubMed ID: 1386280 [TBL] [Abstract][Full Text] [Related]
38. Myocardial blood flow and myocardial uptake of (201)Tl and (99m)Tc-sestamibi during coronary vasodilation induced by CGS-21680, a selective adenosine A(2A) receptor agonist. He ZX; Cwajg E; Hwang W; Hartley CJ; Funk E; Michael LH; Verani MS Circulation; 2000 Jul; 102(4):438-44. PubMed ID: 10908217 [TBL] [Abstract][Full Text] [Related]
39. Comparison of technetium-99m teboroxime tomography with automated quantitative coronary arteriography and thallium-201 tomographic imaging. Fleming RM; Kirkeeide RL; Taegtmeyer H; Adyanthaya A; Cassidy DB; Goldstein RA J Am Coll Cardiol; 1991 May; 17(6):1297-302. PubMed ID: 2016447 [TBL] [Abstract][Full Text] [Related]
40. Effect of triphenyl tetrazolium chloride staining on the distribution of radiolabeled pharmaceuticals. Reinhardt CP; Weinstein H; Wironen J; Leppo JA J Nucl Med; 1993 Oct; 34(10):1722-7. PubMed ID: 7692020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]